Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#390 most reported symptom for this vaccine
Blood creatine phosphokinase normal has been reported 36 times in association with Meningococcal Conjugate (Menactra) vaccination in VAERS. This represents 0.1% of all 36,149 reports for this vaccine.
Among these reports, 2 mentioned death (5.56%) and 17 involved hospitalization (47.2%).
Blood creatine phosphokinase normal is the #390 most frequently reported symptom for Meningococcal Conjugate (Menactra) out of 1843 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 36 reports of Blood creatine phosphokinase normal after Meningococcal Conjugate (Menactra) vaccination may seem alarming, but context is critical.
The 5.56% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.